All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 72 of 206 pages ‹ First < 70 71 72 73 74 > Last ›
HSL11701
Blackwell T.
Another painkiller pulled off shelves
National Post (Toronto) 2007 Oct 5
http://www.canada.com/nationalpost/news/story.html?id=92402f39-9ba9-44b4-bcf4-560d779881f5&k=60355&p=1
HSL11705
Costello D.
FDA drug proposal would bypass the doctor
Los Angeles Times 2007 Oct 5
http://health.usnews.com/usnews/health/healthday/071113/fda-mulls-direct-pharmacist-to-patient-drug-sales.htm
HSL11652
Associated Press.
FDA Asks Lilly to Stop A Cymbalta Mailer
The Wall Street Journal 2007 Oct 4
http://web.archive.org/web/20071012192234/http://online.wsj.com/article/SB119142704134747749.html?mod=googlenews_wsj
HSL11662
Health Canada withdraws Prexige from market
Reuters 2007 Oct 4
http://www.reuters.com/article/healthNews/idUSN0438584020071004
HSL11678
Nagle M.
Eli Lilly: drug safety revolution 'within our grasp'
DrugResearcher.com 2007 Oct 4
http://www.drugresearcher.com/news-by-product/news.asp?id=80305&idCat=0&k=Eli-Lilly--drug-safety
HSL11681
More than 40% of US Physicians Report Improved Services from Pharma, with Merck Rated Highest on Delivering Quality Sales and Service Experiences
PharmaLive 2007 Oct 4
http://pharmalive.com/news/index.cfm?articleID=481098&categoryid=9&newsletter=1
HSL11683
Dooren JC.
FDA May Ease Prescription-Drug Rules
The Wall Street Journal 2007 Oct 4D6
http://online.wsj.com/article/SB119145498280248352.html?mod=rss_Health
HSL11686
Goldstein J.
Is Big Pharma’s Big Tent for Employees Enough?
The Wall Street Journal Health Blog 2007 Oct 4
http://blogs.wsj.com/health/2007/10/04/is-big-pharmas-big-tent-for-employees-enough/
HSL11725
Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A.
Drug shop regulation and malaria treatment in Tanzania why do shops break the rules, and does it matter?
Health Policy Plan 2007 Oct 4;epub ahead of print
http://heapol.oxfordjournals.org/cgi/content/abstract/czm033v1
HSL11745
Shuchman M.
Commercializing clinical trials--risks and benefits of the CRO boom.
N Engl J Med 2007 Oct 4;357:(14):1365-8
http://content.nejm.org/cgi/content/extract/357/14/1365
HSL11643
Koroneos G.
Big Pharma Forms Consortium for Drug Safety
Pharmaceutical Executive 2007 Oct 3
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=461949
HSL11644
Goldstein J.
Drug Info Co’s Sue to Block Rx Privacy Laws
The Wall Street Journal Health Blog 2007 Oct 3
http://blogs.wsj.com/health/2007/10/03/drug-info-cos-sue-to-block-rx-privacy-laws/
HSL11645
Fisher B.
Closure for Bristol-Myers
The Motley Fool 2007 Oct 2
http://www.fool.com/investing/general/2007/10/02/closure-for-bristol-myers.aspx
HSL11647
Johnson A.
Lilly’s Taurel Dreams of Information Revolution
The Wall Street Journal Health Blog 2007 Oct 2
http://blogs.wsj.com/health/2007/10/02/lillys-taurel-dreams-of-information-revolution/?mod=yahoo_hs
HSL11648
Richwine L.
FDA says Lilly's Cymbalta promotion misleading
Reuters 2007 Oct 2
http://www.reuters.com/article/healthNews/idUSN0241655320071002
HSL11682
Carlat D.
The AMA, Pharma Gifts, and the Power of 8
The Carlat Psychiatry Blog 2007 Oct 2
http://carlatpsychiatry.blogspot.com/2007/10/ama-pharma-gifts-and-power-of-8.html
HSL11867
Findings on drug risk welcomed
The Nelson Mail 2007 Oct 2
http://www.stuff.co.nz/stuff/nelsonmail/4223176a6510.html
HSL11633
Goozner M.
The failure of FDA reform
The Guardian 2007 Oct 1
http://commentisfree.guardian.co.uk/merrill_goozner/2007/10/fda_reform.html
HSL11634
Lilly’s Zyprexa on 'deadly drugs' list
PMLive.com 2007 Oct 1
http://www.pmlive.com/index.cfm?showArticle=1&ArticleID=6042
HSL11635
Johnson LA.
Merck still facing long road in court
Associated Press 2007 Oct 1
http://www.nj.com/business/ledger/index.ssf?/base/business-1/119121401197840.xml&coll=1
HSL11639
McKee S.
Alzheimer’s drugs battle rages on; Eisai to appeal
Pharma Times 2007 Oct 1
http://www.pharmatimes.com/WorldNews/ViewArticle.aspx?id=11862
HSL11650
Simons J.
Lessons from a Big Pharma downfall
CNNMoney.com 2007 Oct 1
http://money.cnn.com/2007/10/01/news/companies/wyeth_ceo.fortune/
HSL11684
B-MS pays out $515 million to settle marketing practice probe
Pharma Times 2007 Oct 1
http://www.pharmatimes.com/WorldNews/ViewArticle.aspx?id=11856
HSL11685
Greener M.
DTC ads work, US survey says – and good news for generics
Pharma Times 2007 Oct 1
http://www.pharmatimes.com/WorldNews/ViewArticle.aspx?id=11861
HSL11690
Maeck L, Haak S, Knoblauch A, Stoppe G.
Primary care physicians' attitudes related to cognition enhancers in early dementia: a representative eight-year follow-up study in Lower Saxony, Germany.
Int J Geriatr Psychiatry 2007 Oct 1;
http://www3.interscience.wiley.com/cgi-bin/abstract/116325237/ABSTRACT?CRETRY=1&SRETRY=0
HSL12190
May E.
Tough Losses
Medical Marketing and Media 2007 Oct 1
http://www.mmm-online.com/Tough-Losses/article/35925/
HSL11182
Amran S, Ahmed M, Shaheen SM, Morshed SN, Khandakar J, Rahman M, Rahman M, Hossain A.
Short communication: a study on the packaging information of essential drug products used at Union and Thana health complex level in Bangladesh.
Pak J Pharm Sci 2007 Oct;20:(4):327-32
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17604258&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11438
Ljungberg C, Lindblad AK, Tully MP.
Hospital doctors' views of factors influencing their prescribing.
J Eval Clin Pract 2007 Oct;13:(5):765-71
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2006.00751.x
HSL11523
Thornton S.
Drug price reform in the UK: debunking the myths.
Health Econ 2007 Oct;16:(10):981-92
http://www3.interscience.wiley.com/cgi-bin/abstract/116317701/ABSTRACT?CRETRY=1&SRETRY=0
HSL11524
Kravitz RL, Bell RA.
Direct-to-Consumer Advertising of Prescription Drugs: Balancing Benefits and Risks, and a Way Forward.
Clin Pharmacol Ther 2007 Oct;82:(4):360-2
http://www.nature.com/clpt/journal/v82/n4/abs/6100348a.html;jsessionid=62A01477D87D159A4C7B99B5BF24DAF9
HSL11525
Calfee JE.
An Assessment of Direct-to-Consumer Advertising of Prescription Drugs.
Clin Pharmacol Ther 2007 Oct;82:(4):357-60
http://www.nature.com/clpt/journal/v82/n4/abs/6100353a.html
HSL11589
Holbrook AM, Janjusevic V, Goldsmith CH, Shcherbatykh IY; for the COMPETE Investigators.
A comprehensive appropriateness of prescribing questionnaire was validated by nominal consensus group.
J Clin Epidemiol 2007 Oct;60:(10):1022-1028
http://linkinghub.elsevier.com/retrieve/pii/S0895-4356(07)00040-6
HSL11641
Buchan H.
Turning knowledge into action
Aust Prescr 2007 Oct;30:114-5
http://www.australianprescriber.com/magazine/30/5/114/5/
HSL11642
Cassels A.
The ABCs of disease mongering
Common Ground 2007 Oct
http://commonground.ca/iss/195/cg195_abc.shtml
HSL11651
Sernyak M, Rosenheck R.
Experience of VA Psychiatrists With Pharmaceutical Detailing of Antipsychotic Medications
Psychiatr Serv 2007 Oct;58:(10):1292-1296
http://ps.psychiatryonline.org/cgi/content/abstract/58/10/1292
HSL11707
Haussler B, Schiffhorst G, Gothe H, Hempel E.
The impact of pharmaceuticals on the decline of cardiovascular mortality in Germany.
Pharmacoepidemiol Drug Saf 2007 Oct;16:(10):1167-76
http://www3.interscience.wiley.com/cgi-bin/abstract/114277041/ABSTRACT?CRETRY=1&SRETRY=0
HSL11724
Singh A.
Pharmacogenomics - The potential of genetically guided prescribing.
Aust Fam Physician 2007 Oct;36:(10):820-4
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17925902
HSL11739
Bardelay G.
Pharmaceutical industry: the bugbear of healthcare professionals’ training and patient information
ISDB Newsletter 2007 Oct
http://www.isdbweb.org/documents/uploads/newsletter_open/ISDBNewsletter_October2007_000.pdf
HSL11746
Weiss SC, Krochmal L.
Dermatologists in industry.
J Am Acad Dermatol 2007 Oct;57:(4):725
http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(07)00410-0
HSL11747
Epstein RJ.
Growth of the Asian health-care market: global implications for the pharmaceutical industry.
Nat Rev Drug Discov 2007 Oct;6:(10):785-92
http://www.nature.com/nrd/journal/v6/n10/abs/nrd2360.html;jsessionid=B973221C5A0E598D9CCFEA9F6E717D30
HSL11774
Vitry A, Lexchin J, Mansfield PR.
Is Australia's National Medicines Policy Failing? The Case of Cox-2 Inhibitors
Int J Health Serv 2007 Oct;37:(4):735 - 744
http://baywood.metapress.com/app/home/contribution.asp?referrer=parent&backto=issue,9,13;journal,1,148;linkingpublicationresults,1:300313,1
HSL11793
Davis J.
The Effect of Qualifying Language on Perceptions of Drug Appeal, Drug Experience, and Estimates of Side-Effect Incidence in DTC Advertising.
J Health Commun 2007 Oct-Nov;12:(7):607-22
http://www.informaworld.com/smpp/content?content=10.1080/10810730701615164
HSL11794
Steinman MA, Baron RB.
Is continuing medical education a drug-promotion tool?: YES
Can Fam Physician. 2007 Oct;53:(10):1650-3
http://www.cfp.ca/cgi/content/full/53/10/1650
HSL11795
Marlow B.
Is continuing medical education a drug-promotion tool?: NO.
Can Fam Physician 2007 Oct;53:(10):1650-2,
http://www.cfp.ca/cgi/content/full/53/10/1650-a
HSL11827
MacLean DS.
Drug Overuse: ‘Get Your Doctors to Fix This’
Caring for the Ages 2007 Oct;8:(10):5
HSL11838
Light D.
Misleading Congress about Drug Development
Journal of Health Politics, Policy and Law 2007 Oct;32:(5):895-913
http://web.archive.org/web/20090610012035/http://www.bioethics.upenn.edu/People/?last=Light&first=Donald
HSL11851
Lohr KN.
Emerging methods in comparative effectiveness and safety: symposium overview and summary.
Med Care 2007 Oct;45:(10):
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005650-200710002-00003
HSL11852
Maclure M, Carleton B, Schneeweiss S.
Designed delays versus rigorous pragmatic trials: lower carat gold standards can produce relevant drug evaluations.
Med Care 2007 Oct;45:(10):
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005650-200710002-00010
HSL11853
Sturmer T, Glynn RJ, Rothman KJ, Avorn J, Schneeweiss S.
Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information.
Med Care 2007 Oct;45:(10):
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005650-200710002-00025
HSL11854
Segal JB, Griswold M, Achy-Brou A, Herbert R, Bass EB, Dy SM, Millman AE, Wu AW, Frangakis CE.
Using propensity scores subclassification to estimate effects of longitudinal treatments: an example using a new diabetes medication.
Med Care 2007 Oct;45:(10):
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005650-200710002-00024
HSL11857
Ganz PA, Goodwin PJ.
Health-related quality of life measurement in symptom management trials.
J Natl Cancer Inst Monogr 2007 Oct;(37):47-52
http://jncimono.oxfordjournals.org/cgi/content/abstract/2007/37/47
HSL11858
Rock EP, Scott JA, Kennedy DL, Sridhara R, Pazdur R, Burke LB.
Challenges to use of health-related quality of life for food and drug administration approval of anticancer products.
J Natl Cancer Inst Monogr 2007 Oct;(37):27-30
http://jncimono.oxfordjournals.org/cgi/content/abstract/2007/37/27
HSL11859
Thornton RG.
Preemption, tort reform, and pharmaceutical claims: Part one: Who will become the pharmaceutical industry's insurers (or is it prescribing physicians and we do not know it?)
Proc (Bayl Univ Med Cent). 2007 Oct;20:(4):418-22
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17948120
HSL11862
Ridinger MH.
Nutraceuticals: miracle or meme?
Clin Pharmacol Ther 2007 Oct;82:(4):352-6
http://www.nature.com/clpt/journal/v82/n4/abs/6100354a.html;jsessionid=6C8C2514729C6954195E71C9E7A10812
HSL11865
Biron P, Lévesque P, Plaisance M.
Pharmas-co-dependence exposed: Would it be time to say, 'No thanks'?
Can Fam Physician 2007 Oct;53:(10):1635 - 1637
http://www.cfp.ca/cgi/content/full/53/10/1635
HSL11882
Cassels A.
Big Bucks Big Pharma: New DVD exposes pharma’s ruthless marketing strategies
Common Ground 2007 Oct
http://commonground.ca/iss/195/cg195_bigbucks.shtml
HSL11924
Fitz MM, Homan D, Reddy S, Griffith CH 3rd, Baker E, Simpson KP.
The hidden curriculum: medical students' changing opinions toward the pharmaceutical industry.
Acad Med 2007 Oct;82:(10):
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00001888-200710001-00001
HSL11936
Fallat ME, Glover J; American Academy of Pediatrics, Committee on Bioethics.
Professionalism in pediatrics.
Pediatrics 2007 Oct;120:(4):e1123-33
http://pediatrics.aappublications.org/cgi/content/full/120/4/e1123
HSL12028
Nelson R.
When ads trump evidence: is direct-to-consumer advertising leading practice?
Am J Nurs 2007 Oct;107:(10):25-6
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00000446-200710000-00018
HSL12030
Avanzini G, Engel J Jr.
Dealing with drug dependency: a commentary on ILAE's partnership with the pharmaceutical industry.
Epilepsia 2007 Oct;48:(10):1821-4 Epub 2007 Aug 7
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1528-1167.2007.01255.x
HSL12092
G & S Research Inc
RepReview Pharma 2007 Insights from the Front Line: Sales Representatives and Managers
: G & S Research Inc 2007 Oct
http://www.repreview2007.com/RepReview2007_Synopsis.pdf
HSL12122
Hondeghem LM, De Clerck F, Camm J.
Short patent lives jeopardize drug and patient safety.
J Cardiovasc Pharmacol 2007 Oct;50:(4):353-7
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005344-200710000-00001
HSL12126
Jhung MA, Budnitz DS, Mendelsohn AB, Weidenbach KN, Nelson TD, Pollock DA.
Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES).
Med Care 2007 Oct;45:(10):
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005650-200710002-00017
HSL12127
Crystal S, Akincigil A, Bilder S, Walkup JT.
Studying prescription drug use and outcomes with medicaid claims data: strengths, limitations, and strategies.
Med Care 2007 Oct;45:(10):
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005650-200710002-00012
HSL12156
Oppenheimer J, Aaronson D.
Impact of recent black box warnings in the allergy world.
Ann Allergy Asthma Immunol 2007 Oct;99:(4):364-6
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17941285&dopt=AbstractPlus
HSL12160
FDA and industry happenings.
J Interv Cardiol. 2007 Oct;20:(5):406-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1540-8183.2007.00288.x
HSL12205
Giraldi A, Kristensen E.
Medical solutions have improved the treatment of sexological problems and created more demand for sexological care.
J Sex Marital Ther 2007 Oct-Dec;33:(5):433-7
http://www.informaworld.com/smpp/content?content=10.1080/00926230701477154
HSL12251
Barlow K.
Do we dare use the 'S' word?
Health Care Strateg Manage 2007 Oct;25:(10):15-6
http://www.ncbi.nlm.nih.gov/pubmed/17983034
HSL12252
Szczypka G, Wakefield MA, Emery S, Terry-McElrath YM, Flay BR, Chaloupka FJ.
Working to make an image: an analysis of three Philip Morris corporate image media campaigns.
Tob Control 2007 Oct;16:(5):344-50
http://tobaccocontrol.bmj.com/cgi/content/full/16/5/344
HSL12286
Naito S, Furuta S, Yoshida T, Kitada M, Fueki O, Unno T, Ohno Y, Onodera H, Kawamura N, Kurokawa M, Sagami F, Shinoda K, Nakazawa T, Yamazaki T.
Current opinion: safety evaluation of drug metabolites in development of pharmaceuticals.
J Toxicol Sci 2007 Oct;32:(4):329-41
http://www.jstage.jst.go.jp/article/jts/32/4/32_329/_article
HSL12287
Rankin RC.
The high cost of free lunch.
Obstet Gynecol 2007 Oct;110:(4):932
http://www.greenjournal.org/cgi/content/full/110/4/932
HSL12288
Randall DA.
The high cost of free lunch.
Obstet Gynecol 2007 Oct;110:(4):932
http://www.greenjournal.org/cgi/content/full/110/4/932-a
HSL12289
Frohlich EP.
The high cost of free lunch.
Obstet Gynecol 2007 Oct;110:(4):931
http://www.greenjournal.org/cgi/content/full/110/4/931
HSL12290
Campbell WA.
The high cost of free lunch.
Obstet Gynecol 2007 Oct;110:(4):931-2
http://www.greenjournal.org/cgi/content/full/110/4/931-a
HSL12602
Galm U, Shen B.
Natural product drug discovery: the times have never been better.
Chem Biol 2007 Oct;14:(10):1098-104
http://linkinghub.elsevier.com/retrieve/pii/S1074-5521(07)00332-8
HSL12678
Grieve AP.
25 years of Bayesian methods in the pharmaceutical industry: a personal, statistical bummel.
Pharm Stat 2007 Oct-Dec;6:(4):261-81
http://www3.interscience.wiley.com/cgi-bin/abstract/116833172/ABSTRACT?CRETRY=1&SRETRY=0
HSL12786
Prescriptions for confusion: Some retailers have improved the pill bottle, but the written information that comes with medications is confusing.
Harv Health Lett. 2007 Oct;32:(12):1-2
http://www.ncbi.nlm.nih.gov/pubmed/18246620
HSL12800
Latimer AE, Salovey P, Rothman AJ.
The effectiveness of gain-framed messages for encouraging disease prevention behavior: is all hope lost?
J Health Commun 2007 Oct-Nov;12:(7):645-9
http://www.informaworld.com/smpp/content?content=10.1080/10810730701619695
HSL12801
O'Keefe DJ, Jensen JD.
The relative persuasiveness of gain-framed and loss-framed messages for encouraging disease prevention behaviors: a meta-analytic review.
J Health Commun 2007 Oct-Nov;12:(7):623-44
http://www.informaworld.com/smpp/content?content=10.1080/10810730701615198
HSL12923
Mills S.
Re: The frequency and impact of restless legs syndrome in primary care.
Ir Med J 2007 Oct;100:(9):606
http://www.ncbi.nlm.nih.gov/pubmed/18196890?dopt=Abstract
HSL13164
Anders TF.
The pharmaceutical industry, academic medicine, and the FDA.
J Child Adolesc Psychopharmacol 2007 Oct;17:(5):727-30
http://www.liebertonline.com/doi/abs/10.1089/cap.2007.0093
HSL13251
Bonnemain B.
[Pharmaceutical and parapharmaceutical advertising of Annales vertes in 1927].
Rev Hist Pharm (Paris) 2007 Oct;55:(355):307-28
http://www.ncbi.nlm.nih.gov/pubmed/18348495
HSL13386
Satyanarayana K, Srivastava S.
Poverty, health & intellectual property rights with special reference to India.
Indian J Med Res 2007 Oct;126:(4):390-406
http://www.icmr.nic.in/ijmr/2007/october/1016.pdf
HSL14354
Chaudhry S, Chaudhry S, Chaudhry K.
Point of sale tobacco advertisements in India.
Indian J Cancer 2007 Oct-Dec;44:(4):131-6
http://www.indianjcancer.com/article.asp?issn=0019-509X;year=2007;volume=44;issue=4;spage=131;epage=136;aulast=Chaudhry
HSL11638
Oboh M.
Pfizer faces $8.5 bln suit over Nigeria drug trial
Reuters 2007 Sep 30
http://www.thisislondon.co.uk/standard/article-23414491-pfizer-is-sued-over-nigerian-drug-trials.do
HSL11656
Ten Things Wrong With Medical Journals
The Last Psychiatrist (blog) 2007 Sep 30
http://thelastpsychiatrist.com/2007/09/ten_things_wrong_with_medical.html
HSL12402
Larsson DG, de Pedro C, Paxeus N.
Effluent from drug manufactures contains extremely high levels of pharmaceuticals.
J Hazard Mater 2007 Sep 30;148:(3):751-5
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TGF-4P4FV8H-6&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=7447b86be93edc1676114c3ebcc42b0a
HSL11599
Briggs AH.
New methods of analysing cost effectiveness
BMJ 2007 Sep 29;335:(7621):622
http://www.bmj.com/cgi/content/short/335/7621/622?etoc
HSL11600
Moynihan R.
Healthcare giant advertises to children in classrooms
BMJ 2007 Sep 29;335:(7621):637
http://www.bmj.com/cgi/content/short/335/7621/637-b?etoc
HSL11601
Lilford RJ, Brown CA, Nicholl J
Use of process measures to monitor the quality of clinical practice
BMJ 2007 Sep 29;335:(7621):648
http://www.bmj.com/cgi/content/short/335/7621/648?etoc
HSL11620
Harris G.
Ban Sought on Cold Medicine for Very Young
New York Times 2007 Sep 29
http://www.nytimes.com/2007/09/29/health/29fda.html?_r=1&hp&oref=slogin
HSL11691
Wittkowsky AK.
Dietary supplements, herbs and oral anticoagulants: the nature of the evidence.
J Thromb Thrombolysis 2007 Sep 29;Epub ahead of print
http://www.springerlink.com/content/137351756p547148/
HSL11586
Saltzman J.
Bristol-Myers Squibb to pay $515 million for doctor kickback scheme
The Boston Globe 2007 Sep 28
http://www.boston.com/news/globe/city_region/breaking_news/2007/09/bristolmyers_sq.html
HSL11587
Harris G.
Report Assails F.D.A. Oversight of Clinical Trials
New York Times 2007 Sep 28
http://www.nytimes.com/2007/09/28/health/policy/28fda.html
HSL11603
Rost P.
Bristol-Myers Squibb: Second drug company to pay more than $1 billion in fines.
BrandweekNRx 2007 Sep 28
http://www.brandweeknrx.com/2007/09/bristol-myers-s.html
HSL11604
Sales rep mirroring declines
PMLive.com 2007 Sep 28
http://www.pmlive.com/index.cfm?showArticle=1&ArticleID=6036
HSL11605
Report reveals best-in-class, cross-functional marketing teams
PMLive.com 2007 Sep 28
http://www.pmlive.com/index.cfm?showArticle=1&ArticleID=6038
HSL11625
Bristol-Myers Squibb to Pay More Than $515 Million to Resolve Allegations of Illegal Drug Marketing and Pricing
US Dept of Justice 2007 Sep 28
http://www.usdoj.gov/opa/pr/2007/September/07_civ_782.html
HSL11636
Clarke T.
Novartis has no plans to split CEO, chairman roles
Reuters 2007 Sep 28
http://www.reuters.com/article/health-SP/idUSN2820798120071001?pageNumber=1
HSL11637
Summary Box: Vioxx Anniversary
Associated Press 2007 Sep 28
http://www.bookrags.com/news/summary-box-no-end-in-sight-for-vioxx-moc/
Page 72 of 206 pages ‹ First < 70 71 72 73 74 > Last ›
